Presenters at the AAO 2025 meeting outlined a future for retinal care that reduces patient burden by reconsidering treatment delivery methods.

The Eli Lilly and Company will acquire Adverum Biotechnologies, according to a joint press release issued by the 2 companies.

For the first time, scientists have managed to restore central vision loss from an irreversible age-related eye condition via ...

Second-generation anti-VEGF agents, like aflibercept 8 mg and faricimab, show improved efficacy and treatment durability in ...

A whisper-thin chip, smart glasses and patient training are reshaping how older people live with central vision loss across ...

The shares of the company hit a five-month low as analysts said that the recent development can delay the launch of its new ...

A large propensity-matched retrospective cohort study showed a small but statistically significant 7% increase in new-onset ...

A wireless photovoltaic implant shows promise in restoring central vision for patients with macular degeneration, enhancing visual acuity and independence.

PRIMA wireless retinal implants use photovoltaic tech to improve the sight of people with severe vision loss caused by ...

A new trial shows that a wireless subretinal implant, the PRIMA system, restored central vision in patients with geographic ...

Preliminary studies suggest GLP-1s may offer long-term protection against the eye disease AMD for people without diabetes.

A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...